Mergers & Acquisitions
3 hours ago

Fifth Third to Acquire Comerica in $10.9B All-Stock Deal

The merger will create the ninth-largest U.S. bank, signaling a new wave of consolidation in the regional banking sector.

Read More
Sector Analysis
7 hours ago

US Regional Bank M&A Hits 4-Year High in Q3

A surge in multi-billion dollar deals, led by Fifth Third's $11B acquisition of Comerica, signals a new wave of consolidation.

Read More
Earnings
13 hours ago

James Hardie Shares Surge Over 11% After Boosting Q2 Guidance

Building materials giant cites stronger-than-expected sales and profitability, signaling modest improvement in its key siding market.

Read More
FDA & Biotech
16 hours ago

Jazz Pharma Scores FDA Win for New Lung Cancer Therapy

Zepzelca, in combination with Roche's Tecentriq, approved as first-line maintenance treatment for extensive-stage small cell lung cancer.

Read More
FDA & Biotech
17 hours ago

Lexeo Soars on FDA Fast-Track Talks for Gene Therapy

Regulator signals openness to an accelerated approval pathway for LX2006, a promising treatment for Friedreich's Ataxia cardiomyopathy.

Read More
FDA & Biotech
19 hours ago

Spruce Biosciences Soars 1400% on FDA Breakthrough Drug News

FDA grants Breakthrough Therapy Designation for the company's treatment of Sanfilippo Syndrome, a rare neurodegenerative disorder.

Read More
Mergers & Acquisitions
21 hours ago

Fifth Third to Acquire Comerica in $10.9 Billion All-Stock Deal

The transaction creates the ninth-largest U.S. bank, fueling a new wave of consolidation in the regional banking sector.

Read More
Mergers & Acquisitions
21 hours ago

Occidental Sells Chemical Unit to Berkshire for $9.7 Billion

The energy giant will use the proceeds to accelerate debt reduction and focus on its core oil and gas business.

Read More